BioCrossroads Touts Seed Fund Success

A new report from BioCrossroads shows the investments from three seed funds launched over the last 15 years have proven fruitful. The Indiana Seed Funds from the state's life sciences initiative have... Read More

Hammond Biotech Firm Partners with Australian University

A Hammond-based biotechnology company is teaming up with the University of Western Australia to develop drugs to help fight neurodegenerative diseases and spinal cord injury pain. Neuro Vigor focuses its research on neutralizing reactive aldehydes, which are key to the progression of diseases such as multiple sclerosis, Parkinson’s disease and Alzheimer’s disease. Co-founder and Chief Executive Officer […]... Read More